Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLAS: Patient vs Physician Titration of Insulin Glargine in Asian T2DM
NCT01169818Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2010
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Aug 2010; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01169818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169818.